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Abstract A novel method of photodynamic diagnosis of cancer
mediated by chemiluminescence probe is presented. The mecha-
nism for photodynamic therapy involves singlet oxygen (1O2)
generated by energy transfer from photosensitizers. 1O2 can
react with 3,7-dihydro-6-{4-{2-(NP-(5-£uoresceinyl)thioureido)-
ethoxy}phenyl}-2-methylimidazo{1,2-a}pyrazin-3-one sodium salt
(FCLA), which is a Cypridina luciferin analog and a speci¢c
chemiluminescence probe for detecting 1O2 and superoxide
(O32 ). The reaction of FCLA and
1O2 can give emission with
peak wavelength at about 532 nm. In the present study, FCLA
was chosen as an optical reporter of 1O2 produced from the
photosensitization reaction of hematoporphyrin derivative in
model solution and in nude mice with transplanted mammary
cancer. Photosensitized chemiluminescence from the reaction of
FCLA with 1O2 was detected by a highly sensitive Intensi¢ed
Charge-Coupled Device detector. The chemiluminescence was
markedly inhibited by the addition of 10 mmol/l sodium azide
(NaN3) to the model solution and minor e¡ects were observed at
the addition of 10 Wmol/l superoxide dismutase, 20 mmol/l man-
nitol and 100 Wg/ml catalase, respectively, thus indicating that
1O2 generation from photosensitization reaction mainly results
in light emission. Experiments in vivo with tumor-bearing mice
showed a clear chemiluminescence image of tumor. The study
suggests that this novel method may be applicable to the diag-
nosis of super¢cial tumors. 7 2002 Published by Elsevier Sci-
ence B.V. on behalf of the Federation of European Biochemical
Societies.
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1. Introduction
Photodynamic therapy (PDT) is an evolving modality for
the treatment of cancers. This therapy involves the selective
uptake and retention of a photosensitizer in a tumor, followed
by irradiation with light of a speci¢c wavelength, thereby
initiating tumor necrosis through formation of the reactive
oxygen species (ROS) such as singlet oxygen (1O2) and free
radicals in the irradiated tissues [1,2]. Research has demon-
strated that the destroying e¡ect is mainly due to the forma-
tion of 1O2 (type II PDT process) resulting from the interac-
tion of a light-excited photosensitizer with molecular oxygen
(triplet ground state) [3].
In recent years, the diagnosis of early-stage tumor attracts
more and more attention. Photodynamic diagnosis (PDD) is a
well-known method for tumor localization, which is based on
the accumulation of photosensitizers in a tumor during PDT.
The common PDD is a kind of £uorescence diagnosis, which
detects the £uorescence of photosensitizers excited with their
strongest absorption wavelength. However, the diagnostic ac-
curacy is only about 70% because the main absorption wave-
length of photosensitizers generally used is in the ultraviolet
region. During conventional PDD, using so short excitation
light leads to some serious problems. Firstly, this is the dis-
turbance of auto£uorescence from normal tissues, since in
biological tissues there are many kinds of chromophores
which can be excited by the short wavelength light to emit
strong £uorescence disorderly, which can greatly disturb the
detection of £uorescence from photosensitizers. Secondly, ul-
traviolet irradiation may produce damage in biological tissues.
Thirdly, the poor penetration ability of short wavelength ex-
citation light makes it impossible for diagnosing deeper tu-
mors.
During the PDT process the absorption of photon energy
results in generation of 1O2. It is clear that 1O2 plays an
important role in PDT. Considering the limitations of conven-
tional PDD and the key role of 1O2 in PDT, a novel PDD
method mediated by chemiluminescence probe was put for-
ward and studied by experiments in this report. The method
utilizes a photosensitizer as locator of tumors and a chemilu-
minescence probe as a reporter of 1O2. Thus a tumor can be
shown through detecting the two-dimensional image of the
photosensitized chemiluminescence emitted from the reaction
of the chemiluminescence probe with 1O2 using a highly sen-
sitive Intensi¢ed Charge-Coupled Device (ICCD) detector.
In the present study, hematoporphyrin derivative (HpD)
was used as a photosensitizer [4] and 3,7-dihydro-6-{4-{2-
(NP-(5-£uoresceinyl)thioureido)ethoxy}phenyl}-2-methylimi-
dazo{1,2-a}pyrazin-3-one sodium salt (FCLA) was used as a
chemiluminescence probe of 1O2. FCLA, recently developed
by Goto and co-workers, is characterized by emitting light at
the longest wavelength (532 nm) among the chemiluminescent
substances known up to now [5^7]. Conventional photosensi-
tized reactions of HpD excited by a high-pressure mercury
lamp equipped with a 550 nm long-pass ¢lter were performed
in vitro and in vivo. Experimental results showed that 1O2
generated from photosensitized reaction can be recorded
and imaged in a model system and in tumor-bearing nude
mice.
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2. Materials and methods
2.1. Reagents
FCLA, purchased from Tokyo Kasei Kogyo Co., was dissolved in
double-distilled water and stored at 320‡C until needed. Photosensi-
tizers of HpD (100 mg/20 ml), produced in Beijing Institute of Phar-
maceutical Industry, were diluted in 0.01 mol/l phosphate bu¡er saline
(PBS, pH 7.4) solution before experiments. Cu^Zn superoxide dismu-
tase (SOD, from bovine erythrocytes) and human serum albumin
(HSA; 96%) were obtained from Sigma Chemical Co. Deuterium
oxide (D2O, 99.9 atom % D, from Aldrich Chemical Co.) was stored
under nitrogen until needed. Sodium azide (NaN3), mannitol, catalase
and other chemicals were all made in China.
2.2. Experimental setup
The experimental setup (shown in Fig. 1) used to record the two-
dimensional image of the photosensitized chemiluminescence was
based upon an ICCD detector (model: ICCD-576-s/1, from Princeton
Instruments, USA), which was combined with a photographic lens
of large aperture (Nikon 50 mm, f=1.4) and a detector controller
(ST-130 controller, from Princeton Instruments, USA). The detection
system was a specially designed gated detection. A 50 W high-pressure
mercury lamp (from Bio-Rad) in conjunction with a 550 nm long-pass
¢lter (OG 550, from Coherent Co., USA) was used as the irradiation
source for photosensitization reactions.
All chemiluminescence measurements were carried out at 25‡C. The
specimen, on a tunable stage, was placed in a light-tight box. Through
the photographic lens the chemiluminescence emitted from the speci-
men was collected and imaged onto the sensitive photocathode of the
ICCD detector in appropriate exposure time. The photocathode was
cooled to 340‡C to reduce thermal noise. The spectral response of the
detector was 400^950 nm. The chemiluminescence imaged on the
photocathode by the lens generates photoelectrons, which were multi-
plied by the microchannel plate of the ICCD detector. The two-di-
mensional images of the chemiluminescence were displayed in a
576U384 pixel (picture element) format and processed with WinView
software in a computer. The average counts per unit area were calcu-
lated in the specimen regions after subtraction of the background
counts.
2.3. Preparation of tumor model
Female nude mice with a body weight of about 25 g were used in
this study. A saline suspension of 1U107 disaggregated Bcap-37 hu-
man breast cancer cells was inoculated subcutaneously into the right
shoulder of the mice, which caused a tumor to grow at a super¢cial
place. The photosensitized chemiluminescence measurements were
performed 2 weeks after inoculation.
2.4. Measurement of photosensitized chemiluminescence mediated by
FCLA in model solution
A photosensitizer in PBS solution containing serum albumin such
as bovine serum albumin and HSA appears to be a good model for
PDT in vivo [8]. In our experiments, a standard quartz cuvette
(1U1U4 cm) was used for measurements of photosensitized chemilu-
minescence in vitro. Components of the model solution were prepared
just before use. The standard reaction mixture contained 20 Wmol/ml
HpD, 5 Wmol/l HSA, 2 Wmol/l FCLA and 0.01 mol/l PBS at pH 7.4 in
a total volume of 1 ml. The model solution on the stage was irradiated
uniformly for 20 s with a power density of 0.2 W/cm2. Then the
photosensitized chemiluminescence was recorded immediately after
the irradiation was stopped. As contrast, the chemiluminescence was
also detected when either HpD or FCLA was omitted from the model
solution. To con¢rm the origin of photosensitized chemiluminescence,
various ROS quenchers and D2O were added to the model solution
before irradiation and the e¡ects of quenchers and D2O on chemilu-
minescence intensity were recorded and compared. In order to prevent
the quenchers added from photosensitized destruction during irradi-
ation, the amounts of quenchers were increased in experiments. The
quenchers used included 10 mmol/l NaN3, 10 Wmol/l SOD, 20 mmol/l
mannitol and 100 Wg/ml catalase.
2.5. Measurement of photosensitized chemiluminescence mediated by
FCLA in tumor-bearing nude mouse
When the tumor reached approximately 1000 mm3 in volume after
2 weeks of inoculation, the nude mouse was injected with 200 Wg HpD
in 0.9% sodium chloride systemically through a tail vein. After a
period of 24 h to allow localization of HpD in the tumor, the mouse
was given a super¢cial injection of 0.5 ml of 5 WM FCLA into the
tumor and at the same time, as a contrast, the equivalent amount of
FCLA was injected subcutaneously in the intact nape of the mouse.
Then after a period of 60 min for FCLA to di¡use, the mouse was
anaesthetized with sodium pentobarbital (50 mg/kg, i.p.). Afterwards
the mouse was placed on the black stage in the light-tight box.
The mouse in the light-tight box was irradiated uniformly for 60 s
with a power density of 0.4 W/cm2 to allow a photosensitization
reaction to occur in vivo. Photosensitized chemiluminescence medi-
ated by FCLA was recorded immediately after the irradiation was
stopped.
3. Results
3.1. Measurement of photosensitized chemiluminescence
mediated by FCLA in model solution
In experiments, we observed that the model solution con-
taining HpD, HSA and FCLA in PBS showed considerable
light emission immediately after the irradiation was stopped
and the light emission intensity attenuated rapidly with time,
which could last for about 180 s. The photosensitization
chemiluminescence images of the model solution recorded
for the ¢rst 30 s after irradiation are given in Fig. 2. In con-
trast, the images with minor chemiluminescence intensity are
Fig. 1. The schematic setup of the two-dimensional photosensitized chemiluminescence imaging system.
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also recorded when either HpD or FCLA was omitted from
the model solution prior to the performance of irradiation
(results are shown in Fig. 2). The comparison of chemilumi-
nescence intensity in Fig. 2 is given in Fig. 3. Fig. 4 shows the
time course of photosensitized chemiluminescence.
3.2. E¡ects of quenchers and D2O on photosensitized
chemiluminescence mediated by FCLA in model solution
FCLA can selectively react with both 1O2 and O32 and give
chemiluminescence with a wavelength of 532 nm [7]. 1O2 and
O32 can be eliminated by NaN3 and SOD in appropriate
amounts, respectively. In order to con¢rm the e¡ect of 1O2
on the photosensitized chemiluminescence mediated by
FCLA, several quenchers and D2O were tested in our experi-
ments (results are given in Fig. 5). We observed that the
addition of the O32 scavenger SOD, the H2O2 scavenger cata-
lase and cOH scavenger mannitol to the above model solution
prior to the performance of irradiation did not cause a very
signi¢cant decrease (decreased by 23.5%, 12.8% and 8.7%,
respectively, compared with control) in the integral chemilu-
minescence intensity of the ¢rst 30 s after irradiation was
stopped. However, the integral chemiluminescence intensity
was markedly inhibited (about 69.5%) by NaN3, which is an
e¡ective quencher of 1O2. Considering the excellent selectivity
of FCLA to 1O2 and O32 , the results suggested that the photo-
sensitized reaction of HpD mostly elicits the formation of 1O2
but not of O32 . (Because of the selectivity of FCLA, in our
experiments the generation of cOH and H2O2 in photosensi-
tization action of HpD cannot be known well.) The photo-
sensitization reaction of HpD by the substitution of D2O for
H2O is often used as evidence that 1O2 is involved, since the
lifetime of 1O2 is approximately 10 times longer in D2O than
in H2O, thus allowing it more time to exert e¡ects on targets
Fig. 2. Images of photosensitized chemiluminescence mediated by FCLA in model solution (exposure time is 30 s). A: Light emission from
PBS (10 mmol/l, pH 7.4) with HSA (5 Wmol/l), HpD (20 Wmol/l) and visible light (s 550 nm, 20 s), in the absence of FCLA. B: Light emission
from PBS (10 mmol/l, pH 7.4) with HSA (5 Wmol/l), HpD (20 Wmol/l), FCLA (2 Wmol/l) and visible light (s 550 nm, 20 s). C: Light emission
from PBS (10 mmol/l, pH 7.4) with HSA (5 Wmol/l), FCLA (2 Wmol/l) and visible light (s 550 nm, 20 s), in the absence of HpD.
Fig. 3. Comparison of photosensitized chemiluminescence intensity
of samples in Fig. 2 with histogram. Data are presented as
meanUS.D. of at least three separate experiments.
Fig. 4. Time course of photosensitized chemiluminescence in model
solution with PBS (10 mmol/l, pH 7.4), HSA (5 Wmol/l), HpD
(20 Wmol/l), FCLA (2 Wmol/l) and visible light (s 550 nm, 20 s).
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[9]. The result of photosensitized chemiluminescence in D2O is
also shown in Fig. 5.
3.3. Imaging of photosensitized chemiluminescence
mediated by FCLA in tumor-bearing nude mouse
Fig. 6 shows the images obtained from a photosensitized
tumor-bearing nude mouse. The image of (A) in Fig. 6 was
obtained on illuminating the mouse with dim white light. This
was done for the purpose of positioning the mouse and the
tumor. The tumor was located in the right shoulder of the
mouse. The photosensitized chemiluminescence image re-
corded for the ¢rst 60 s after irradiation is shown as (B) in
Fig. 6. The luminescent area in (B) of Fig. 6 corresponds to
the tumor region. No clear chemiluminescence was observed
around the intact nape and other regions of the mouse.
4. Discussion
Since it was discovered that porphyrin-based photosensitive
dyes preferentially accumulated in malignant tissues, HpD has
undergone extensive experimental and clinical research as a
photosensitizer for PDT of tumors [10^12].
The photodynamic e¡ect is a result of three primary pro-
cesses. First, the ground state of the sensitizer (S0) is optically
excited to produce the excited singlet state (1S1). Population
from this excited state is transferred by intersystem crossing (a
radiationless transition) to the lowest triplet state (3S1) of the
sensitizer. The triplet state photosensitizer may exert damag-
ing e¡ects through two main mechanisms, of type I and type
II. In a type I reaction, electron transfer from the triplet
sensitizer produces free radicals. In a type II reaction, colli-
sional energy transfer from the triplet sensitizer to ground-
state molecular oxygen (3O2) produces highly reactive 1O2
and returns the sensitizer to its ground state:
S0 þ hX ! 1S1
1S1 ! 3S1
3S1 þRH! free radicals ðtype I; electron transferÞ
3S1 þ 3O2 ! S0 þ 1O2 ðtype II; energy transferÞ
Free radicals and 1O2 produced as results of type I and type
II mechanisms can react readily with many biological targets
and destroy a wide variety of cells.
For many years attention has concentrated on the type II
production of 1O2, which has frequently been suggested to be
the major intermediate for photodynamic actions both in vitro
Fig. 5. E¡ects of quenchers and D2O on photosensitized chemilumi-
nescence mediated by FCLA in model solution. The quenchers and
D2O (99.9 atom % D) were added before irradiation with visible
light (s 550 nm, 20 s). Quenchers used are the 1O2 quencher NaN3
(10 mmol/l), the O32 scavenger SOD (10 Wmol/l), the cOH scavenger
mannitol (20 mmol/l) and the H2O2 scavenger catalase (100 Wg/ml).
Data are presented as meanUS.D. of at least three separate experi-
ments. *P6 0.05 in comparison with control; **P6 0.01 in compar-
ison with control.
Fig. 6. Image of photosensitized chemiluminescence mediated by FCLA in tumor-bearing nude mouse. A: Image of nude mouse obtained on il-
lumination with dim white light. The tumor can be observed in the right shoulder. Two black crosses indicate the position where FCLA was
administered. B: Photosensitized chemiluminescence image from the tumor-bearing nude mouse. The bright area corresponds to the tumor re-
gion. No clear light emission was recorded over the nape. Exposure time is 60 s immediately after irradiation with visible light (s 550 nm,
60 s).
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and in vivo [13,14]. In this study, the results of photosensi-
tized chemiluminescence mediated by FCLA demonstrated
the 1O2 formation from photosensitization reaction of HpD,
and the e¡ects of azide inhibition and deuterium enhancement
further veri¢ed 1O2 generation. Our study also shows the O32
generation from the photosensitization reaction but the
amounts are minor and of no signi¢cance. The production
of H2O2 and cOH cannot be known well in our experiments
because of the selectivity of FCLA to 1O2 and O32 .
As a sensitive chemiluminescence probe, FCLA can selec-
tively react with 1O2 and O32 to give emission at 532 nm [15]:
FCLAþ 1O2 or O32 ! FCLANO
! FCLANOþ hX ð532 nmÞ
Combination of the 1O2 production from the photosensiti-
zation reaction and the FCLA reaction with 1O2 makes it
possible to observe photosensitized chemiluminescence medi-
ated by FCLA in vitro and in vivo. In the model system, very
faint emission was observed when either HpD or FCLA was
omitted. The emission of the model solution without FCLA
may directly come from direct de-excitation of 1O2 or reaction
of excited photosensitizers with HSA, and emission without
HpD may be from the slow auto-oxygenation of FCLA by
dissolved oxygen [16].
In a tumor-bearing nude mouse, due to the accumulation of
HpD in malignant tissues, a clear photosensitization chemilu-
minescence image of the tumor was obtained. The appreciable
light emission of this FCLA-mediated chemiluminescence
makes it possible to apply this method to the diagnosis of
cancer. Although this novel method can only be adapted to
the detection of emission from super¢cial tumors at present,
because the emission wavelength of FCLA (532 nm) is too
short to penetrate biological tissue, it should be pointed out
that the auto£uorescence can be avoided completely with this
method.
Data indicate that in vivo during the exponential growth of
tumors, native free radicals accumulate and reach a relatively
high steady state [17]. So in the course of photosensitization in
vivo a competition occurs between 1O2-mediated e¡ects and
the interactions between the triplet photosensitizer and native
free radicals formed in tumor cells. These facts might interfere
with the method and might be one of the reasons why the
chemiluminescence intensity recorded in vivo is much lower
than in solution. However, the fact of oxygen existing in the
tumors makes it possible to produce 1O2 in vivo during pho-
tosensitization though its amount is less than in solution.
Also, the high e⁄ciency and selectivity of FCLA trapping
1O2 enable us to observe the 1O2 generation in vivo with
the FCLA-mediated chemiluminescence.
Since the ICCD used is very sensitive to light and in order
to avoid the disturbance of scattered light, £uorescence and
phosphorescence, we did not record the FCLA-mediated
chemiluminescence at the same time as the irradiation but
recorded it immediately after the excitation was shut down.
The present results indicate that 1O2 production in photo-
sensitization reaction of HpD can be detected by FCLA-medi-
ated chemiluminescence, which is named photosensitized
chemiluminescence in this report. Utilizing the photosensitized
chemiluminescence method to detect tumors in nude mice, a
clear emission image was obtained. With this novel method,
longer wavelength irradiation light (s 550 nm) is converted to
shorter wavelength chemiluminescence (532 nm), so the dis-
turbance of auto£uorescence can be avoided completely.
5. Conclusions
This study demonstrates that the main product from the
photosensitization reaction of HpD is 1O2 but not O32 . The
1O2 produced from photosensitized reaction can be detected
with the chemiluminescence probe of FCLA. In vivo photo-
sensitized chemiluminescence imaging was performed with a
tumor-bearing nude mouse and a clear tumor image was ob-
tained. The photosensitized chemiluminescence mediated by
FCLA can be used as a novel PDD method of tumors and
has potential applications in clinics for tumor diagnosis.
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